Although most human neuroblastoma cells exhibit drug resistance because of their low levels of caspase-8 expression, previous reports have shown that TRAIL-receptor 2 (TRAIL-R2/DR5/TNFRSF10b) is an important upstream effector of caspase-8 [34]. Here, CASP8 is linked to neuroblastoma.